top of page

NEWS

Biotechnology, Drug Discovery, CNS and Rare Disease, Life Science Industry

DNA Strand

CELLECTIS GETS FDA PASS TO CONTINUE ITS CLINICAL TRIAL OF THE NOVEL CAR-T CELL THERAPY

November 6, 2017

Embryonic Stem Cells

NOVARTIS SEEKS LYMPHOMA MARKET FOR THEIR CAR-T CELL THERAPY

November 2, 2017

cells-1872666.jpg

FDA APPROVED KITE'S YESCARTA FOR NON-HODGKIN LYMPHOMA; GILEAD SHARE ROSE

October 18, 2017

DNA

BLUEBIRD'S GENE THERAPY SHOWED PROMISE FOR LORENZO'S OIL DISEASE

Oct 6, 2017

bottom of page